Epidermolysis Bullosa Clinical Trials in Thessaloniki
3 recruitingThessaloniki, Greece
Showing 1–3 of 3 trials
Recruiting
Phase 2Phase 3
An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS)
Generalized Epidermolysis Bullosa Simplex
TWi Biotechnology, Inc.80 enrolled36 locationsNCT06073132
Recruiting
Phase 2
A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study
Dystrophic Epidermolysis BullosaEpidermolysis Bullosa (EB)Junctional Epidermolysis Bullosa
Xinnate AB32 enrolled6 locationsNCT06594393
Recruiting
A Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez
Epidermolysis Bullosa, DystrophicEpidermolysis Bullosa, Junctional
Amryt Pharma580 enrolled5 locationsNCT06423573